These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9545384)

  • 1. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
    Dickinson CD; Shobe J; Ruf W
    J Mol Biol; 1998 Apr; 277(4):959-71. PubMed ID: 9545384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the catalytic function of coagulation factor VIIa by a conformational linkage of surface residue Glu 154 to the active site.
    Shobe J; Dickinson CD; Ruf W
    Biochemistry; 1999 Mar; 38(9):2745-51. PubMed ID: 10052945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
    Edgington TS; Mackman N; Fan ST; Ruf W
    Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S15-27. PubMed ID: 1364116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A; Ruf W; Rao LV
    Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
    Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
    Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
    Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS
    Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
    Carlsson K; Persson E; Carlsson U; Svensson M
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1111-6. PubMed ID: 16970919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
    Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
    Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status on tissue factor activation of factor VIIa.
    Persson E; Olsen OH
    Thromb Res; 2010 Apr; 125 Suppl 1():S11-2. PubMed ID: 20153879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa.
    Dickinson CD; Kelly CR; Ruf W
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14379-84. PubMed ID: 8962059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
    Jin J; Perera L; Stafford D; Pedersen L
    J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies.
    Kirchhofer D; Moran P; Chiang N; Kim J; Riederer MA; Eigenbrot C; Kelley RF
    Thromb Haemost; 2000 Dec; 84(6):1072-81. PubMed ID: 11154116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity.
    Jin J; Chang J; Chang JY; Kelley RF; Stafford DW; Straight DL
    Biochemistry; 1999 Jan; 38(4):1185-92. PubMed ID: 9930978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
    Persson E; Olsen OH
    FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicted solution structure of zymogen human coagulation FVII.
    Perera L; Darden TA; Pedersen LG
    J Comput Chem; 2002 Jan; 23(1):35-47. PubMed ID: 11913388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quest for Factor VIIa exosite inhibitors.
    Amour A; Hutchinson J; Ruiz Avendaño AM; Ratcliffe S; Alvarez E; Martin J; Toomey JR; Senger S; Wolfendale M; Mooney C
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):555-8. PubMed ID: 17511650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active site modification of factor VIIa affects interactions of the protease domain with tissue factor.
    Dickinson CD; Ruf W
    J Biol Chem; 1997 Aug; 272(32):19875-9. PubMed ID: 9242651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
    Zhang E; St Charles R; Tulinsky A
    J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.
    Freskgård PO; Olsen OH; Persson E
    Protein Sci; 1996 Aug; 5(8):1531-40. PubMed ID: 8844844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.